Companies / Aldeyra Therapeutics, Inc. / Activity
Activity — Aldeyra Therapeutics, Inc.
22 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | Alfieri Michael Executive | Buy | Common Stock | $7.1K | +5K +200.00% | 7,500 0.01% of shares | low |
| Mar 19, 2026 | Douglas Richard Director | Buy | Common Stock | $98.0K | +70K +56.00% | 195,000 0.32% of shares | medium |
| Jun 3, 2026 | Brady Todd C CEO | Buy | Common Stock | $418.4K | +250K +16.99% | 1,721,298 2.85% of shares | medium |
| Jun 9, 2026 | Miller-Rich Nancy Director | Grant | Stock Option (Right to Buy) | — | +3K | 3,318 <0.01% of shares | low |
| Jun 9, 2026 | Miller-Rich Nancy Director | Grant | Stock Option (Right to Buy) | — | +70K | 70,000 0.12% of shares | low |
| Jun 9, 2026 | Clark William D Director | Grant | Stock Option (Right to Buy) | — | +2K | 2,323 <0.01% of shares | low |
| Jun 9, 2026 | Clark William D Director | Grant | Stock Option (Right to Buy) | — | +70K | 70,000 0.12% of shares | low |
| Jun 9, 2026 | Walker Neal Director | Grant | Stock Option (Right to Buy) | — | +3K | 3,318 <0.01% of shares | low |
| Jun 9, 2026 | Walker Neal Director | Grant | Stock Option (Right to Buy) | — | +70K | 70,000 0.12% of shares | low |
| Jun 9, 2026 | Bronstein Ben Director | Grant | Stock Option (Right to Buy) | — | +5K | 4,977 <0.01% of shares | low |
| Jun 9, 2026 | Bronstein Ben Director | Grant | Stock Option (Right to Buy) | — | +5K | 5,309 <0.01% of shares | low |
| Jun 9, 2026 | Bronstein Ben Director | Grant | Stock Option (Right to Buy) | — | +70K | 70,000 0.12% of shares | low |
| Jun 9, 2026 | Phillips Gary M. Director | Grant | Stock Option (Right to Buy) | — | +5K | 4,977 <0.01% of shares | low |
| Jun 9, 2026 | Phillips Gary M. Director | Grant | Stock Option (Right to Buy) | — | +7K | 6,636 0.01% of shares | low |
| Jun 9, 2026 | Phillips Gary M. Director | Grant | Stock Option (Right to Buy) | — | +70K | 70,000 0.12% of shares | low |
| Jun 9, 2026 | Deptula-Hicks Darlene M Director | Grant | Stock Option (Right to Buy) | — | +10K | 9,756 0.02% of shares | low |
| Jun 9, 2026 | Deptula-Hicks Darlene M Director | Grant | Stock Option (Right to Buy) | — | +85K | 84,557 0.14% of shares | low |
| Jun 9, 2026 | Douglas Richard Director | Grant | Stock Option (Right to Buy) | — | +2K | 2,323 <0.01% of shares | low |
| Jun 9, 2026 | Douglas Richard Director | Grant | Stock Option (Right to Buy) | — | +20K | 19,909 0.03% of shares | low |
| Jun 9, 2026 | Douglas Richard Director | Grant | Stock Option (Right to Buy) | — | +70K | 70,000 0.12% of shares | low |
| Mar 27, 2026 | Brady Todd C CEO | Grant | Bonus Units | — | +632K | 632,318 1.05% of shares | low |
| Mar 27, 2026 | Brady Todd C CEO | Grant | Stock Option (right to buy) | — | +1.9M | 1,880,510 3.12% of shares | low |